Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07102290 · ClinicalTrials.gov registry record · NA

Pragmatic Trial of Text Messages to Recruit Unassisted Tobacco Users Into Quitline Service

A NA study, sponsored by University of California, Davis.

Completed
Registry status
NA
Development phase
4,171
Enrollment target

NCT07102290: Completed NA study, sponsored by University of California, Davis.

NCT07102290 is a NA study that has completed, run by University of California, Davis. The registered enrollment target is 4,171 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (197% higher). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07102290, a NA study, has completed, sponsored by University of California, Davis.

COMPLETED
Registry status
NA
Development phase
4,171 participants
Enrollment target

Study Summary

The goal of this pragmatic trial is to compare the effects of text messages on quitline enrollment by patients identified in electronic health records as unassisted tobacco users. The main question it aims to answer is: Do messages offering free counseling or free nicotine patches by text increase quitline enrollment? Researchers will compare if people receiving texts about free nicotine patches will have higher quitline enrollment than texts about free counseling. Participants will receive a text message stratified by quitline language and click on the toll-free number to access quitline services.

Primary Outcome

Proportion of patients (identified as a tobacco user who has not received cessation assistance) calling the quitline from the link in the text message

Interventions

  • BEHAVIORAL Free Help
  • BEHAVIORAL Free Nicotine message
  • BEHAVIORAL Spanish: Free help message
  • BEHAVIORAL Spanish: Free nicotine message

Trial Details

FieldValue
Enrollment Target 4,171 participants
Start Date 2022-04-01
Est. Completion 2022-08-31
Phase NA
University of California, Davis

657 total trials

What the finished NCT07102290 record still lists

NCT07102290 is an interventional study that assigns participants to a tested intervention. Its 4,171 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (197% higher).

The record links to 0 conditions, and to 4 interventions - of which Free Help is the first listed.

NCT07102290 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT07102290 about?

NCT07102290 is a clinical study titled "Pragmatic Trial of Text Messages to Recruit Unassisted Tobacco Users Into Quitline Service". The goal of this pragmatic trial is to compare the effects of text messages on quitline enrollment by patients identified in electronic health records as unassisted tobacco users. The main question it aims to answer is: Do messages offering free counseling or free nicotine patches by text increase ...

What is the current status of trial NCT07102290?

This trial is currently completed. It is a NA study. The enrollment target is 4,171 participants. The study started on 2022-04-01. Estimated completion is 2022-08-31.

What interventions are being tested in trial NCT07102290?

The interventions under investigation include: Free Help (BEHAVIORAL), Free Nicotine message (BEHAVIORAL), Spanish: Free help message (BEHAVIORAL), Spanish: Free nicotine message (BEHAVIORAL).

Who is sponsoring clinical trial NCT07102290?

This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT07102290's enrollment target sits among peer trials

4,171 31st of 2000 higher than 1,970 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06593353 · 4,165 participants · NA

    Systems Analysis and Improvement to Optimize Opioid Use Disorder Care Quality and Continuity for Patients Exiting Jail

  • NCT02693535 · 4,200 participants · Phase 2

    TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer

  • NCT05969028 · 4,200 participants · NA

    First Responder Airway & Compression Rate Trial

  • NCT06935370 · 4,200 participants · Phase 3

    A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07102290, the US trial registry maintained by the National Library of Medicine. NCT07102290 (large enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.